Slingshot Insights

Catalyst

Slingshot members are tracking this event:

Janssen to Unveil New Hepatitis B and C Data at The International Liver Congress

Source Link:: http://www.investor.jnj.com/releaseDetail.cfm?ReleaseID=962949

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies

Importance

High

Medium

Low

Impact on Stocks

JNJ

100%

SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details Janssen will present thirteen abstracts featuring new data on an investigational regimen for treatment of hepatitis B virus (HBV) and approved and investigational regimens for the treatment of hepatitis C virus (HCV) at the upcoming International Liver Congress. The abstracts will focus on treatments NVR 3-778, simeprevir, AL-335, and JNJ-54257099.

http://www.investor....

Slingshot Insights Explained

JOIN FOR FREE TODAY

Catalyst Date

Occurred on:

Apr 14, 2016

Occurred Source:

http://www.ncbi.nlm.nih.gov/pubmed/26704148

Related Projects

Don’t see a project related to the catalyst you care about?

Related Keywords Hepatitis B, Hepatitis C, Nvr 3-778, Simeprevir, Al-335, Jnj-54257099, Data Abstracts